Latest Acquisition Lands AxoSim in the News
News and Blog
On Tuesday, October 24, 2023, AxoSim announced the completion of its acquisition of the microBrain™-associated assets of Vyant Bio’s StemoniX subsidiary—news of the acquisition generated excitement among the scientific, pharmaceutical, and business communities. From The […]
Read More
Press Release: AXOSIM EXTENDS LEADERSHIP IN HUMAN ORGANOIDS FOR NEUROLOGICAL DRUG DISCOVERY WITH ACQUISITION OF STEMONIX MICROBRAIN™ TECHNOLOGY
News and Blog
New Orleans, La. ─ October 24, 2023 ─ AxoSim, Inc., a leader in the development and application of live biomimetic human drug discovery platforms for neurological diseases, today announced completion of its acquisition of the microBrain™-associated assets of […]
Read More
AxoSim and its Co-Founder, Michael Moore, PhD, Quoted in the Wire
News and Blog
WIRED recently quoted our Co-Founder Michael J. Moore and mentioned AxoSim and our 3D peripheral nerve model. The article highlights 3d printing of living brain cells from a team of scientists at Monash University. Excerpt […]
Read More
Q&A with Research Assistant Intern Andrew Terrebonne
News and Blog
Tell us the school you attend, grade level and major. I am currently a senior at Tulane University majoring in cell and molecular biology. Why did you want to intern with us at AxoSim? While […]
Read More
Press Release: AxoSim Enters Into a Definitive Agreement to Acquire Vyant Bio’s StemoniX Assets
News and Blog
AxoSim Enters Into a Definitive Agreement to Acquire Vyant Bio’s StemoniX Assets —Combines Three Leading Human Biomimetic Organoid Platform Technologies for Neurological Drug Discovery— —AxoSim Gains microBrainTM Intellectual Property from StemoniX, Along With Expert Scientific […]
Read More
Meet AxoSim | Summer 2023 Conference Schedule
News and Blog
On the Road with AxoSim’s Conference Team | Q&A with Senior Business Development Manager Chelsea Richardson What upcoming conferences is AxoSim a part of this summer? A portion of our team will be headed to […]
Read More
AxoSim 2022 Year in Review
News and Blog
AxoSim’s 2022 Year in Review publication highlights company achievements, technology highlights and goals moving into 2023. View the full report featuring Q&As with our scientists below. Read Report
Read More
Press Release: AxoSim Celebrates Lab Expansion at NOBIC
News and Blog
Read Article in The Times-Picayune | Nola.com AxoSim and New Orleans BioInnovation Center Celebrate Lab Expansion The new space will provide 2,000 more square feet for AxoSim research in the heart of the BioDistrict NEW […]
Read More
AxoSim Welcomes Edward “Ted” Spack as its Executive Director of Research & Development
News and Blog
AxoSim is honored to welcome Edward “Ted” Spack, PhD, as its new Executive Director of Research and Development. Ted brings more than 30 years of start-up biotech experience, including co-founding a biotech and mentoring local […]
Read More
AxoSim Team at SOT 2023!
News and Blog
Meet us at SOT 2023 | March 19-23 2023 | Nashville, TN We will be on the road for the SOT 2023 Annual Meeting in Nashville, TN. We are excited to have two poster presentations […]
Read More